Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics.

Literature DB >> 11986989

Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics.

H K Manji¹, C A Zarate.

Abstract

Entities: Disease

Mesh：

Year: 2002 PMID： 11986989 DOI： 10.1038/sj.mp.4001068

Source DB: PubMed Journal: Mol Psychiatry ISSN： 1359-4184 Impact factor: 15.992

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study.

Authors: Lobna Ibrahim; Wallace Duncan; David A Luckenbaugh; Peixiong Yuan; Rodrigo Machado-Vieira; Carlos A Zarate
Journal: Brain Res Bull Date: 2011-06-16 Impact factor: 4.077

2. Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin.

Authors: Anton Terasmaa; Ursel Soomets; Julia Oflijan; Marite Punapart; Mats Hansen; Vallo Matto; Kersti Ehrlich; Anne Must; Sulev Kõks; Eero Vasar
Journal: J Physiol Biochem Date: 2011-04-02 Impact factor: 4.158

3. Rapid cycling bipolar disorders in primary and tertiary care treated patients.

Authors: Tomas Hajek; Margaret Hahn; Claire Slaney; Julie Garnham; Joshua Green; Martina Růzicková; Peter Zvolský; Martin Alda
Journal: Bipolar Disord Date: 2008-06 Impact factor: 6.744

Review 4. Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.

Authors: Rodrigo Machado-Vieira; Giacomo Salvadore; Lobna A Ibrahim; Nancy Diaz-Granados; Carlos A Zarate
Journal: Curr Pharm Des Date: 2009 Impact factor: 3.116

Review 5. A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder.

Authors: Nancy DiazGranados; Carlos A Zarate
Journal: Curr Psychiatry Rep Date: 2008-12 Impact factor: 5.285

Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics.

1. Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study.

2. Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin.

3. Rapid cycling bipolar disorders in primary and tertiary care treated patients.

Review 4. Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.

Review 5. A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder.

Review 6. Bipolar disorder: candidate drug targets.

7. Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling.

Review 8. Avoiding drug-induced switching in patients with bipolar depression.

Review 9. Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder.

10. Effect of Tamoxifen and Lithium on Treatment of Acute Mania Symptoms in Children and Adolescents.